Loading live market data…

Adverum Biotechnologies, Inc.

NASDAQ:ADVM

$4.36 USD

$0 (0.0%)

Volume
675.98K
Average Volume
724.34K
Market Capitalization
$96.26M
P/E Ratio
-0.66
Dividend Yield
0.00%
Price Target
$5.00
Year High
$6.07
Year Low
$1.78
Day High
Day Low
Payout Ratio
$0.00
Current Ratio
$0.65
Source Headline

Get ADVM Insider Trade Alerts

ADVM Price Target Summary

Last Month

$0.00

0 analysts

Last Quarter

$0.00

0 analysts

Last Year

$4.83

3 analysts

All Time

$10.81

8 analysts

ADVM Recent Analyst Grades

Date Analyst Firm Action Previous Grade New Grade
2025-11-17 HC Wainwright & Co. Downgrade Buy Neutral
2025-10-28 RBC Capital Maintain Sector Perform Sector Perform
2025-09-23 HC Wainwright & Co. Maintain Buy Buy
2025-08-13 Chardan Capital Maintain Buy Buy
2025-06-26 Mizuho Maintain Outperform Outperform
2025-05-15 Chardan Capital Maintain Buy Buy
2025-05-15 HC Wainwright & Co. Maintain Buy Buy
2025-05-15 RBC Capital Maintain Sector Perform Sector Perform
2025-04-17 Chardan Capital Maintain Buy Buy
2025-04-16 RBC Capital Maintain Sector Perform Sector Perform
2025-04-16 HC Wainwright & Co. Maintain Buy Buy
2024-11-19 HC Wainwright & Co. Maintain Buy Buy
2024-11-05 RBC Capital Maintain Sector Perform Sector Perform
2024-08-14 Truist Securities Maintain Buy Buy
2024-08-13 HC Wainwright & Co. Maintain Buy Buy
2024-08-13 HC Wainwright& Co. Maintain Buy Buy
2024-08-13 RBC Capital Maintain Sector Perform Sector Perform
2024-07-18 Chardan Capital Maintain Buy Buy
2024-05-15 Truist Securities Maintain Buy Buy
2024-05-10 HC Wainwright & Co. Maintain Buy Buy
2024-04-29 Mizuho Maintain Buy Buy
2024-03-19 RBC Capital Maintain Sector Perform Sector Perform
2024-03-19 Chardan Capital Maintain Buy Buy
2024-02-06 Mizuho Maintain Buy Buy
2023-09-05 Truist Securities Maintain Buy Buy
2023-08-11 Chardan Capital Upgrade Neutral Buy
2023-03-07 Ladenburg Thalmann Maintain Buy Buy
2022-11-11 RBC Capital Maintain Sector Perform Sector Perform
2022-11-11 Chardan Capital Maintain Neutral Neutral
2022-08-12 Chardan Capital Maintain Neutral Neutral
2022-07-07 Truist Securities Upgrade Hold Buy
2021-07-23 Chardan Capital Maintain Neutral Neutral
2021-07-23 SVB Leerink Maintain Market Perform Market Perform
2021-07-23 Cantor Fitzgerald Downgrade Overweight Neutral
2021-05-03 SVB Leerink Downgrade Outperform Market Perform
2021-04-29 RBC Capital Downgrade Outperform Sector Perform
2021-04-29 Truist Securities Downgrade Buy Hold
2021-04-29 SVB Leerink Maintain Outperform Outperform
2021-04-29 Chardan Capital Downgrade Buy Neutral
2020-11-12 Raymond James Upgrade Underperform Market Perform
2020-08-11 SVB Leerink Maintain Outperform Outperform
2020-05-13 RBC Capital Maintain Outperform Outperform
2020-05-05 SVB Leerink Maintain Outperform Outperform
2020-05-05 SunTrust Robinson Humphrey Upgrade Hold Buy
2020-04-28 Goldman Sachs Maintain Buy Buy
2020-03-16 SVB Leerink Maintain Outperform Outperform
2020-02-10 Chardan Capital Upgrade Neutral Buy
2020-02-10 Cantor Fitzgerald Upgrade Neutral Overweight
2020-01-13 PiperJaffray Maintain Overweight Overweight
2019-09-13 SunTrust Robinson Humphrey Maintain Hold Hold
2018-11-05 Cantor Fitzgerald Downgrade Overweight Neutral
2018-11-02 Raymond James Downgrade Outperform Market Perform
2018-11-02 SunTrust Robinson Humphrey Downgrade Buy Hold
2018-09-21 Cantor Fitzgerald Maintain Overweight Overweight
2018-08-30 SunTrust Robinson Humphrey Maintain Buy Buy
2017-10-12 Raymond James Maintain Outperform Outperform
2016-06-08 Chardan Capital Downgrade Buy Neutral
2016-03-01 Chardan Capital Maintain Buy Buy
2015-06-23 Chardan Capital Upgrade Sell Neutral
2015-06-16 Chardan Capital Downgrade Neutral Sell
2015-06-16 SunTrust Robinson Humphrey Downgrade Buy Neutral
2015-06-16 William Blair Downgrade Outperform Market Perform
2015-03-26 Jefferies Maintain Buy Buy
2015-03-10 SunTrust Robinson Humphrey Maintain Buy Buy
2015-02-19 Chardan Capital Maintain Neutral Neutral
2015-02-13 Jefferies Maintain Buy Buy
2014-08-25 PiperJaffray Maintain Overweight Overweight
2014-08-25 Jefferies Maintain Buy Buy
2014-08-25 Cowen & Co. Maintain Outperform Outperform
2014-08-25 William Blair Maintain Outperform Outperform